Dra. Eva Baldrich Rubio

Head of Group
Email: eva.baldrich@vhir.org
Phone: 934893754 / ext 3754

Research Group

Diagnostic Nanotools


Dr. Baldrich obtained a Degree in Biology at the Universitat Autonoma de Barcelona (Spain) in 1993. During the last two years of those studies, she joined the Genetics and Microbiology department as a collaborating student, where she later gained a Masters Degree in Molecular Genetics (1995) and a PhD in Biological Sciences (1998).

Her pre-doctoral work focussed on molecular genetics of transponible elements and, specifically, in the molecular characterization of the transposition event. She then moved to the Haematology Department of the University of Cambridge (UK). There, she worked in the isolation of new HIV virus variants and in the study of blood samples obtained from patients hospitalized in Central Africa (Gana, Togo, Ivory Coast and Benin) in an attempt to isolate new viruses causing AIDS-like symptoms.

In 2002 she joined the Nanotechnology and Bioanalysis Group (NBG) at the Universitat RoviraV irgili (Tarragona, Spain), where we participated for three years in the development of electrochemical aptasensors for the fast and sensitive detection of thrombin, a cardiovascular biomarker. In 2006 she became a member of the BioMEMS group at the Institut Nacional de Microelectrònica de Barcelona (IMB-CNM, CSIC), where she was the responsible of the Biosensor’s laboratory.

Over the following eight years, she contributed to the design, development and optimization of immunoassays and immunosensors for detection of, among others, bacteria, cardiac biomarkers, hormones, and neurotransmitters. Since 2014, Dr. Baldrich leads the Diagnostics Nanotools Group at CIBBIM-Nanomedicine.

  • Her main areas of expertise include:
    Surface bioengineering for the efficient incorporation of bioreceptors (antibodies, aptamers, enzymes) onto surfaces of different materials and via different chemical paths.
  • Fast assay development, in an attempt to shorten and/or simplify pre-existing assays or define novel strategies for fast assay performance.
  • Integration of pre-defined detection and bioengineering strategies in microelectrodes and devices in order to produce biosensors.